IPO

Mankind Pharma Ltd. (“Mankind”) is India’s 4th largest pharmaceutical company in terms of Domestic sales and 3 rd largest in terms of sales volume for MAT (Moving An nual Total) December 2022 engaged in diverse range of pharmaceutical formulation across acute and chronic therapeutic areas.

Mankind benefits from the industry experience and business acumen of their individual Promoters and is driven by the 3 core values of quality, affordability and accessibility. Their professional and experienced management team has been critical in building their brands, growing their operations, and maintaining capital efficiency despite their emphasis on affordable product offerings.

MPL focuses primarily on the domestic market (98% of sales) with market share increasing from 4.1% to 4.3% over FY20 - MAT Dec’22 with sales growing at 12% CAGR v/s IPM (Indian Pharmaceutical Market) growth of around 10% for the same period.

Mankind Pharma Ltd (MPL) is the fourth largest pharmaceutical company in India by domestic sales and third largest by sales volume. With 97% of its revenue from India, MPL sells pharmaceutical formulations and consumer healthcare goods, and operates 25 manufacturing sites and a specialised R&D centre with four divisions.

Issue Snapshot: Issue Open: Apr 25 Apr 27, 2023 Price Band: Rs. 1026 1080 *Issue Size: 4326.36 cr (Entirely Offer for Sale of 40,058,844 eq sh) Reservation for: QIB upto 50% eq sh Non-Institutional atleast 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail atleast 35% eq sh Face Value: Rs 1 Book value: Rs 178.38 (December 31, 2022) Bid size: - 13 equity shares and in multiples thereof 100% Book built Issue IPO Note - Mankind Pharma Limited

Mankind is a well?known player in the domestic pharma market (with 97.6% of sales), and is 4th largest in terms of sales and 3rd largest in terms of sales volume as on Dec’22 MAT. About 36 brands in the Pharma business, which has sales over Rs500mn, with strong brand positioning. In the consumer segment, it has leading brands i.e Manforce, Prega News, Unwanted?72, which are having significant market share in their
respective categories.

Issue Snapshot: Issue Open: Apr 03 Apr 06, 2023 Price Band: Rs. 415 436 *Issue Size: 865.0 cr (Fresh Issue of Rs 320.0 cr + Offer for sale of 545.0 cr) Reservation for: QIB atleast 75% eq sh Non-Institutional upto 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail upto 10% eq sh Face Value: Rs 2 Book value: Rs 26.37 (November 30, 2022) Bid size: - 34 equity shares and in multiples thereof 100% Book built Issue IPO Note-Avalon Technologies Limited